Literature DB >> 9920865

Enzyme activity of macrophage migration inhibitory factor toward oxidized catecholamines.

J Matsunaga1, D Sinha, L Pannell, C Santis, F Solano, G J Wistow, V J Hearing.   

Abstract

Macrophage migration inhibitory factor (MIF) is a relatively small, 12.5-kDa protein that is structurally related to some isomerases and for which multiple immune and catalytic roles have been proposed. MIF is widely expressed in tissues with particularly high levels in neural tissues. Here we show that MIF is able to catalyze the conversion of 3,4-dihydroxyphenylaminechrome and norepinephrinechrome, toxic quinone products of the neurotransmitter catecholamines 3,4-dihydroxyphenylamine and norepinephrine, to indoledihydroxy derivatives that may serve as precursors to neuromelanin. This raises the possibility that MIF participates in a detoxification pathway for catecholamine products and could therefore have a protective role in neural tissues, which as in Parkinson's disease, may be subject to catecholamine-related cell death.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9920865     DOI: 10.1074/jbc.274.6.3268

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  The role of macrophage migration inhibitory factor in Alzheimer's disease.

Authors:  Michael Bacher; Oliver Deuster; Bayan Aljabari; Rupert Egensperger; Frauke Neff; Frank Jessen; Julius Popp; Carmen Noelker; Jens Peter Reese; Yousef Al-Abed; Richard Dodel
Journal:  Mol Med       Date:  2010-02-28       Impact factor: 6.354

2.  A small-molecule inhibitor of macrophage migration inhibitory factor for the treatment of inflammatory disease.

Authors:  Aaron P Kithcart; Gina M Cox; Thais Sielecki; Abigail Short; James Pruitt; Tracey Papenfuss; Todd Shawler; Ingrid Gienapp; Abhay R Satoskar; Caroline C Whitacre
Journal:  FASEB J       Date:  2010-07-12       Impact factor: 5.191

3.  Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.

Authors:  Vinay Trivedi-Parmar; William L Jorgensen
Journal:  J Med Chem       Date:  2018-06-04       Impact factor: 7.446

Review 4.  Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.

Authors:  L Zecca; D Tampellini; M Gerlach; P Riederer; R G Fariello; D Sulzer
Journal:  Mol Pathol       Date:  2001-12

Review 5.  Stromal-dependent tumor promotion by MIF family members.

Authors:  Robert A Mitchell; Kavitha Yaddanapudi
Journal:  Cell Signal       Date:  2014-09-30       Impact factor: 4.315

6.  MCP-1 expression in CNS-1 astrocytoma cells: implications for macrophage infiltration into tumors in vivo.

Authors:  Tammy Kielian; Nico van Rooijen; William F Hickey
Journal:  J Neurooncol       Date:  2002-01       Impact factor: 4.130

7.  Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.

Authors:  Peter D Senter; Yousef Al-Abed; Christine N Metz; Fabio Benigni; Robert A Mitchell; J Chesney; Jianlin Han; Carlos G Gartner; Sidney D Nelson; George J Todaro; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

8.  Neurotoxicity due to o-quinones: neuromelanin formation and possible mechanisms for o-quinone detoxification.

Authors:  F Solano; V J Hearing; J C García-Borrón
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

Review 9.  Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.

Authors:  Beatriz E Rendon; Sharon S Willer; Wayne Zundel; Robert A Mitchell
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

10.  Serum macrophage migration inhibitory factor in the prediction of preterm delivery.

Authors:  Brad D Pearce; Sicily E Garvin; Jakob Grove; Elizabeth A Bonney; Donald J Dudley; Diana E Schendel; Poul Thorsen
Journal:  Am J Obstet Gynecol       Date:  2008-02-01       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.